Directory
>
Soujanya Sunkaraneni
Soujanya Sunkaraneni
Executive Director, Head of DMPK & Clinical pharmacology | Syndax Pharmaceuticals
Boston, Massachusetts, United States
Soujanya Sunkaraneni
Summary
Soujanya Sunkaraneni is a seasoned professional with over 16 years of experience in clinical pharmacology and drug development. Currently serving as the Executive Director and Head of DMPK and Clinical Pharmacology at Syndax Pharmaceuticals, Soujanya has a rich background in biostatistics and pharmacometrics. Her expertise spans across various therapeutic areas, including oncology and CNS disorders, where she has leveraged model-based strategies to optimize drug development processes. Soujanya is known for her innovative approaches to pharmacokinetic modeling and simulation, which have significantly reduced costs and development timelines. She holds advanced degrees in Pharmacology and Pharmacometrics, showcasing her commitment to continuous learning and excellence in her field. Soujanya has been recognized with multiple awards for her contributions to the pharmaceutical industry, highlighting her leadership and impact. With a strong foundation in both scientific and managerial roles, she is well-positioned to drive strategic initiatives in clinical research and development.
Soujanya Sunkaraneni
Work Experience
Executive Director, Head of DMPK & Clinical pharmacology at
Syndax Pharmaceuticals
July 2024 - Present
Senior director, Head of DMPK and Clinical Pharmacology at
Syndax Pharmaceuticals
July 2022 - July 2024
Scientific Director, Clinical pharmacology at
Takeda
October 2020 - July 2022
Associate Director, Clinical pharmacology at
Blueprint Medicines
September 2018 - October 2020
Principal Modeling and Simulations Scientist at
Sunovion Pharmaceuticals
April 2016 - September 2018
Modeling and Simulation Scientist at
Sunovion Pharmaceuticals
April 2014 - March 2016
Clinical Pharmacokinetic Research Associate at
Sunovion Pharmaceuticals
May 2011 - April 2014
Consultant -Clinical PK Research Associate at
Sepracor Pharmaceuticals
May 2007 - May 2011
Soujanya Sunkaraneni
Education
University of Maryland, Baltimore (UMB), Master's Degree
January 2012 - January 2016
St. John's University (New York City), Masters
January 2004 - January 2007
Kakatiya University, Bachelor's Degree
January 2001 - January 2004
Frequently Asked Questions about Soujanya Sunkaraneni
What is Soujanya Sunkaraneni email address?
Soujanya Sunkaraneni's primary email address is ************@syndax.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Soujanya Sunkaraneni work for?
Soujanya Sunkaraneni is a Executive Director, Head of DMPK & Clinical pharmacology at Syndax Pharmaceuticals, a company specializing in Commercial physical research.
Where Soujanya Sunkaraneni graduated from?
Soujanya Sunkaraneni holds a degree in Pharmacometrics, Center For Translational Medicine from University of Maryland, Baltimore (UMB).
How can I directly contact Soujanya Sunkaraneni?
To contact Soujanya Sunkaraneni directly, you can use the email address ************@syndax.com. Complete contact information is available upon registration with Muraena.
Who is Soujanya Sunkaraneni?
Soujanya Sunkaraneni is a seasoned professional with over 16 years of experience in clinical pharmacology and drug development. Currently serving as the Executive Director and Head of DMPK and Clinical Pharmacology at Syndax Pharmaceuticals, Soujanya has a rich background in biostatistics and pharmacometrics. Her expertise spans across various therapeutic areas, including oncology and CNS disorders, where she has leveraged model-based strategies to optimize drug development processes. Soujanya is known for her innovative approaches to pharmacokinetic modeling and simulation, which have significantly reduced costs and development timelines. She holds advanced degrees in Pharmacology and Pharmacometrics, showcasing her commitment to continuous learning and excellence in her field. Soujanya has been recognized with multiple awards for her contributions to the pharmaceutical industry, highlighting her leadership and impact. With a strong foundation in both scientific and managerial roles, she is well-positioned to drive strategic initiatives in clinical research and development.
Soujanya`s contact details
************@syndax.com
Colleagues
Chief Scientific Officer
BD Mentor
VP, clinical development
Executive Director, Clinical Sciences, Revumenib Lead
Executive Director, Clinical Data Management
Vice President Regulatory Affairs and QA
Vice President, Investor Relations and Corporate Communications
Vice President Information Technology
VP, CMC
Vice President, Talent and Experience